Printer Friendly

COMPANY INFORMATION
Paladin Labs Inc. 102-6111 av Royalmount Montréal, QC H4P 2T4 Tel: (514) 340-1112 Toll-free: (888) 376-7830 Fax: (514) 344-4675 Contact Name Samira Sakhia Industry Pharmaceuticals		Key Executives Jonathan R. Goodman, CEO Samira Sakhia, CFO Markets and sells prescription pharmaceutical products in Canada, primarily in the fields of urology, endocrinology, and women's health.
FP ADVISOR COVERAGE Paladin Labs Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/PLB $18.98 $20.50 $10.00 n.a. n.a. n.a. 0.59 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 12,308 7.80 $2.44 Sept. 30/09 49.8% 19.9% 31.92% $351,437
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 82,744 62,941 48,357 Net income 13,798 9,033 5,806 Total assets 132,140 98,905 85,851 $ $ $ Earnings per share* 0.93 0.60 0.39 % % % Return on equity 15.56 11.60 8.29   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 103,465 77,390 Net income 39,462 8,712 $ $ Earnings per share 2.52 0.58

COMPANY NEWS

Results for 'Paladin Labs Inc.' from past 30 days: No hits. (Links are to articles.)